Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update).
作者信息
Grunfeld Eva, Dhesy-Thind Sukhbinder, Levine Mark
机构信息
Dalhousie University, Halifax, NS.
出版信息
CMAJ. 2005 May 10;172(10):1319-20. doi: 10.1503/cmaj.045062.
Abstract
摘要
相似文献
1
Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update).
CMAJ. 2005 May 10;172(10):1319-20. doi: 10.1503/cmaj.045062.
2
3
Adjuvant chemotherapy and cognitive dysfunction in breast cancer patients.
J Support Oncol. 2006 Feb;4(2):66-7.
4
Breast cancer and "chemobrain": the consequences of cognitive difficulties following chemotherapy and the potential for recovery.
Mo Med. 2009 Mar-Apr;106(2):127-31.
5
The impact of new European Organisation for Research and Treatment of Cancer guidelines on the use of granulocyte colony-stimulating factor on the management of breast cancer patients.
Eur J Cancer. 2008 Feb;44(3):353-65. doi: 10.1016/j.ejca.2007.11.024. Epub 2008 Jan 11.
6
Does cognitive impairment after chemotherapy for breast cancer improve over time or does practice make perfect?
J Clin Oncol. 2006 Nov 10;24(32):5170-1; author reply 5171-2. doi: 10.1200/JCO.2006.07.8303.
7
The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
Patient Educ Couns. 2007 Apr;66(1):108-18. doi: 10.1016/j.pec.2006.11.005. Epub 2007 Feb 21.
8
Cognitive adverse effects of chemotherapy in breast cancer patients.
Curr Opin Support Palliat Care. 2007 Apr;1(1):57-62. doi: 10.1097/SPC.0b013e32813a328f.
9
Effects of specific neuropsychological training programs for breast cancer patients after adjuvant chemotherapy.
J Psychosoc Oncol. 2009;27(2):274-96. doi: 10.1080/07347330902776044.
10
Managing weight gain after breast cancer.
J Support Oncol. 2006 Feb;4(2):69-70.
引用本文的文献
1
ESR Essentials: post-treatment breast cancer surveillance from mammography to a more personalised approach-practice recommendations by the European Society of Breast Imaging.
Eur Radiol. 2025 Aug 14. doi: 10.1007/s00330-025-11819-3.
2
App-Based Lifestyle Intervention (PINK! Coach) in Breast Cancer Patients-A Real-World-Data Analysis.
Cancers (Basel). 2024 Feb 29;16(5):1020. doi: 10.3390/cancers16051020.
3
The Risk of Lymphedema After Breast Cancer Surgery Should Not Restrict Necessary Hand Surgery Interventions.
Hand (N Y). 2024 Sep;19(6):995-1001. doi: 10.1177/15589447231155583. Epub 2023 Feb 21.
4
Web-Based Asynchronous Tool to Facilitate Communication Between Primary Care Providers and Cancer Specialists: Pragmatic Randomized Controlled Trial.
J Med Internet Res. 2023 Jan 18;25:e40725. doi: 10.2196/40725.
5
Does Routine Follow-Up after Patients Have Completed Adjuvant Therapy for Early-Stage Breast Cancer at a Cancer Center Improve Prognosis?
Breast Care (Basel). 2022 Jun;17(3):249-256. doi: 10.1159/000519533. Epub 2021 Nov 23.
6
Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities.
Geburtshilfe Frauenheilkd. 2022 Feb 11;82(2):181-205. doi: 10.1055/a-1671-2446. eCollection 2022 Feb.
7
Specialist breast care nurses for support of women with breast cancer.
Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD005634. doi: 10.1002/14651858.CD005634.pub3.
8
Effect of Tai Chi Chuan in Breast Cancer Patients: A Systematic Review and Meta-Analysis.
Front Oncol. 2020 Apr 23;10:607. doi: 10.3389/fonc.2020.00607. eCollection 2020.
9
Adherence to quality breast cancer survivorship care in four Canadian provinces: a CanIMPACT retrospective cohort study.
BMC Cancer. 2019 Jul 4;19(1):659. doi: 10.1186/s12885-019-5882-z.
10
Opportunities for personalised follow-up care among patients with breast cancer: A scoping review to identify preference-sensitive decisions.
Eur J Cancer Care (Engl). 2019 May;28(3):e13092. doi: 10.1111/ecc.13092. Epub 2019 May 9.
本文引用的文献
1
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.
Lancet. 2005;365(9453):60-2. doi: 10.1016/S0140-6736(04)17666-6.
2
Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer.
J Natl Cancer Inst. 2003 Oct 1;95(19):1467-76. doi: 10.1093/jnci/djg060.
3
Weight loss in breast cancer patient management.
J Clin Oncol. 2002 Feb 15;20(4):1128-43. doi: 10.1200/JCO.2002.20.4.1128.
4
Follow-up after treatment for breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
CMAJ. 1998 Feb 10;158 Suppl 3:S65-70.
5
Life after breast cancer: understanding women's health-related quality of life and sexual functioning.
J Clin Oncol. 1998 Feb;16(2):501-14. doi: 10.1200/JCO.1998.16.2.501.
6
Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients.
J Clin Oncol. 1997 Apr;15(4):1341-7. doi: 10.1200/JCO.1997.15.4.1341.
Zotero 插件